Kamada KMDA
NASDAQ KMDA
$8.31 +0.11 (+1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kamada (KMDA) Cost of Revenue (2012 - 2026)

Updated

Kamada (KMDA) recorded Cost of Revenue of $32.45 million in the quarter ended Jun 30, 2026, up 25.7% from $25.83 million a year earlier and up 24.2% from the prior quarter.

Analysis

Kamada (KMDA) Cost of Revenue (2012 - 2026) Analysis & Trends

On a TTM basis, Kamada's Cost of Revenue came in at $113.54 million as of Jun 30, 2026, up 18.8% year-over-year; for the year ended Dec 31, 2025, it came in at $104.05 million, up 14.4% from the prior year.

  • Annual Cost of Revenue has increased for four straight years, with a five-year compound annual growth rate of 4.0% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Cost of Revenue came in at $90.99 million in the year ended Dec 31, 2024 (+4.5%), $87.03 million in the year ended Dec 31, 2023 (+5.3%), $82.64 million in the year ended Dec 31, 2022 (+12.7%) and $73.31 million in the year ended Dec 31, 2021 (-14.4%).
  • The figure for the quarter ended Jun 30, 2026 is the highest quarterly Cost of Revenue since the quarter ended Sep 30, 2017.
  • On a year-over-year basis, Cost of Revenue has increased for six consecutive quarters, with growth averaging 12.7% over the last eight quarters.
  • Peak year-over-year performance for Cost of Revenue in the last five years was growth of 40.7% in the quarter ended Jun 30, 2023, against a decline of 27.0% in the quarter ended Dec 31, 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $26.12 million (quarter ended Mar 31, 2026), $27.71 million (quarter ended Dec 31, 2025) and $27.25 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Kamada 479.37 Mn 188.43 Mn 22.47 Mn 32.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32.45 Mn
Mar 31, 2026 26.12 Mn
Dec 31, 2025 27.71 Mn
Sep 30, 2025 27.25 Mn
Jun 30, 2025 25.83 Mn
Mar 31, 2025 23.27 Mn
Dec 31, 2024 21.97 Mn
Sep 30, 2024 24.51 Mn
Jun 30, 2024 23.52 Mn
Mar 31, 2024 20.99 Mn
Dec 31, 2023 22.02 Mn
Sep 30, 2023 23.13 Mn
Jun 30, 2023 23.01 Mn
Mar 31, 2023 18.87 Mn
Dec 31, 2022 30.15 Mn
Sep 30, 2022 19.35 Mn
Jun 30, 2022 16.35 Mn
Mar 31, 2022 16.79 Mn
Dec 31, 2021 24.87 Mn
Sep 30, 2021 17.30 Mn
API Access

Kamada Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=KMDA&period=max&api_key=YOUR_API_KEY